ProBioGen Pharmaceutical Cell Line Development Service by ProBioGen AG

Manufacturer ProBioGen AG
Stable, High-Yield Mammalian Producer Cell Lines. ProBioGen's in-house cell line engineering platform enables them to provide our clients with pharmaceutical producer clones that exceed the limits of the current industrial standard, while still supporting a royalty-free fee-for-service business model.ProBioGen have built a fully integrated technology platform that encompasses the key actuating variables: Host Cell Line, Vector Technology and clone-adapted Media Platform.Key Advantages of P... Read more


ProBioGen Pharmaceutical Cell Line Development Service by ProBioGen AG product image
ProBioGen Pharmaceutical Cell Line Development Service

The supplier does not provide quotations for this particular product through SelectScience. You can search for similar products in our product directory.



0 Scientists have reviewed this product


Write the First Review

No Reviews

Stable, High-Yield Mammalian Producer Cell Lines.

ProBioGen's in-house cell line engineering platform enables them to provide our clients with pharmaceutical producer clones that exceed the limits of the current industrial standard, while still supporting a royalty-free fee-for-service business model.

ProBioGen have built a fully integrated technology platform that encompasses the key actuating variables: Host Cell Line, Vector Technology and clone-adapted Media Platform.


Key Advantages of ProBioGens Production Cell Lines:

  • Expression Yield - Achieve predictable and stable high mAb-expression levels in the 1–4 g/L range (non-optimized fed batch). ProBioGen antibody expression cassettes thus employ fine-tuned promoters and other genetic regulatory elements to support a perfectly balanced and synchronized subunit expression.
  • Upstream Performance and Scalability - Key upstream performance parameters (qp, IVCD, titer) remain consistent during upscale. The value of a candidate clone typically becomes apparent once it is used in a regulated fermentation process at process development scale. This "Bioreactor Performance Analysis" (BPA) is of high predictive value and assures maintenance of clone performance up to large-scale fermenters.
  • Clone Stability - ProBioGen's producer clones maintain a consistently stable and high transgene expression level throughout the duration of the manufacturing time window.
  • Regulatory Acceptance - The documentation for our production clones addresses all aspects covered in the relevant guidelines (ICH-Harmonized Tripartite Guidelines, EMA/FDA Points to Consider and Notes for Guidance) and contains submission-ready data to be included in the "body of data" section 3.2 of Module 3, CTD.